Nontuberculous mycobacterial (NTM) lung disease: The top ten essentials

Respiratory Medicine

Volumn 108, Issue 3, 2014, Pages 417-425

  Aksamit, Timothy R ^a   Philley, Julie V ^b   Griffith, David E ^b  

^a Mayo Clinic College of Medicine   (United States)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Mycobacterium abscessus; Mycobacterium avium Complex (MAC); Nontuberculous mycobacteria

Indexed keywords

MACROLIDE;

BRONCHIECTASIS; HUMAN; IN VITRO STUDY; LUNG DISEASE; MONOTHERAPY; MYCOBACTERIUM ABSCESSUS LUNG DISEASE; MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE; MYCOBACTERIUM INTRACELLULARE AVIUM; NON CYSTIC FIBROSIS BRONCHIECTASIS; NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RADIOGRAPHY; REVIEW; TRADITIONAL TUBERCULOSIS; TUBERCULOSIS;

MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM COMPLEX (MAC); NONTUBERCULOUS MYCOBACTERIA;

BRONCHIECTASIS; FEMALE; HUMANS; LUNG DISEASES; MACROLIDES; MALE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; SEX FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES;

EID: 84896697001     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.09.014     Document Type: Review

References (50)

1. D.E. Griffith, T. Aksamit, and B.A. Brown-Elliott et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases Am J Respir Crit Care Med 175 2007 367 416
2. L.M. Feazel, L.K. Baumgartner, and K.L. Peterson et al. Opportunistic pathogens enriched in showerhead biofilms Proc Natl Acad Sci U S A 106 2009 16393 16399
3. Y. Nishiuchi Nishiuchi, R. Maekura, S. Kitada, A. Tamaru, T. Taguri, Y. Kira, T. Hiraga, A. Hirotani, K. Yoshimura, M. Miki, and M. Ito The recovery of Mycobacteriumavium-intracellulare complex (MAC) from the residential bathrooms of patients with pulmonary MAC Clin Infect Dis 45 3 2007 Aug 1 347 351 [Epub 2007 Jun 15]
4. J.O. Falkinham 3rd Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease Emerg Infect Dis 17 3 2011 Mar 419 424
5. T.K. Marras, R.J. Wallace Jr., and L.L. Koth et al. Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water Chest 127 2005 664 671
6. J.O. Falkinham 3rd, M.D. Iseman, P. de Haas, and D. van Soolingen Mycobacterium avium in a shower linked to pulmonary disease J Water Health 6 2008 209 213
7. M.A. Dirac, K.L. Horan, D.R. Doody, J.S. Meschke, D.R. Park, L.A. Jackson, N.S. Weiss, K.L. Winthrop, and G.A. Cangelosi Environment or host?: a case-control study of risk factors for Mycobacterium avium complex lung disease Am J Respir Crit Care Med 186 7 2012 Oct 1 684 691
8. R.D. Kim, D.E. Greenberg, and M.E. Ehrmantraut et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome Am J Respir Crit Care Med 178 2008 1066 1074
9. M. Kartalija, A.R. Ovrutsky, C.L. Bryan, G.B. Pott, G. Fantuzzi, J. Thomas, M.J. Strand, X. Bai, P. Ramamoorthy, M.S. Rothman, V. Nagabhushanam, M. McDermott, A.R. Levin, A. Frazer-Abel, P.C. Giclas, J. Korner, M.D. Iseman, L. Shapiro, and E.D. Chan Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes Am J Respir Crit Care Med 187 2 2013 Jan 15 197 205
10. H.N. Mai, M. Hijikata, Y. Inoue, K. Suzuki, M. Sakatani, M. Okada, K. Kimura, N. Kobayashi, E. Toyota, K. Kudo, H. Nagai, A. Kurashima, A. Kajiki, N. Oketani, H. Hayakawa, G. Tanaka, J. Shojima, I. Matsushita, S. Sakurada, K. Tokunaga, and N. Keicho Pulmonary Mycobacterium avium complex infection associated with the IVS8-T5 allele of the CFTR gene Int J Tuberc Lung Dis 11 2007 808 813.9
11. T. Bienvenu, I. Sermet-Gaudelus, P.R. Burgel, D. Hubert, B. Crestani, L. Bassinet, D. Dusser, and I. Fajac Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis Am J Respir Crit Care Med 181 10 2010 May 15 1078 1084 [Epub 2010 Feb 18]
12. K.L. Winthrop, E. Chang, and S. Yamashita et al. Nontuberculous mycobacteria infections and antitumor necrosis factor-alpha therapy Emerg Infect Dis 15 2009 1556 1561
13. M.D. Iseman, and T.K. Marras The importance of nontuberculous mycobacterial lung disease Am J Respir Crit Care Med 178 2008 999 1000
14. D.R. Prevots Prevots, P.A. Shaw, D. Strickland, L.A. Jackson, M.A. Raebel, M.A. Blosky, R. Montes de Oca, Y.R. Shea, A.E. Seitz, S.M. Holland, and K.N. Olivier Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems Am J Respir Crit Care Med 182 2010 970 976
15. K.L. Winthrop Winthrop, E. McNelley, B. Kendall, A. Marshall-Olson, C. Morris, M. Cassidy, A. Saulson, and K. Hedberg Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease Am J Respir Crit Care Med 182 2010 977 982
16. J. van Ingen, M.J. Boeree, and W.C. de Lange et al. Clinical relevance of Mycobacterium szulgai in The Netherlands Clin Infect Dis 46 2008 1200 1205
17. J. van Ingen, M.J. Boeree, and P.N. Dekhuijzen et al. Clinical relevance of Mycobacterium simiae in pulmonary samples Eur Respir J 31 1 2008 106 109
18. S. Park, G.Y. Suh, and M.P. Chung et al. Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens Respir Med 102 2008 437 442
19. H.J. Jun, K. Jeon, and S.W. Um et al. Nontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis Respir Med 103 2009 1936 1940
20. S. Kitada, K. Kobayashi, S. Ichiyama MAC Serodiagnosis Study Group Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit Am J Respir Crit Care Med 177 2008 793 797
21. G.L. Woods, B. Brown-Elliott, P.S. Conville, E.P. Desmond, G.S. Hall, G. Lin, and B.E. Pfyffer et al. Susceptibility testing of mycobacteria, norcardia, and other aerobic actinomycetes Approved Standard-Second Edition 2003 Clinical and Laboratory Standards Institute (CLSI) CLSI document M24-A2
22. Y. Kobashi, M. Abe, K. Mouri, Y. Obase, S. Kato, and M. Oka Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period J Infect Chemother 18 4 2012 Aug 436 443
23. Y. Kobashi, M. Abe, K. Mouri, Y. Obase, N. Miyashita, and M. Oka Clinical usefulness of combination chemotherapy for pulmonary Mycobacterium avium complex disease J Infect 0163-4453 20 November 2010 10.1016/j.jinf.2010.11.011 Available online
24. E. Tanaka, T. Kimoto, K. Tsuyuguchi, I. Watanabe, H. Matsumoto, A. Niimi, K. Suzuki, T. Murayama, R. Amitani, and F. Kuze Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease Am J Respir Crit Care Med 160 1999 866 872
25. R.J. Wallace Jr., B.A. Brown, D.E. Griffith, W.M. Girard, and D.T. Murphy Clarithromycin regimens for pulmonary Mycobacterium avium complex: the first 50 patients Am J Respir Crit Care Med 153 1996 1766 1772
26. K.A. Nash, Y. Zhang, B.A. Brown-Elliott, and R.J. Wallace Jr. Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum J Antimicrob Chemother 55 2005 170 177
27. K.A. Nash, B.A. Brown-Elliott, and R.J. Wallace Jr. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae Antimicrob Agents Chemother 53 2009 1367 1376
28. J. van Ingen, M.J. Boeree, D. van Soolingen, and J.W. Mouton Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria Drug Resist Updat 15 3 2012 Jun 149 161
29. Y. Ito, T. Hirai, K. Maekawa, K. Fujita, S. Imai, S. Tatsumi, T. Handa, H. Matsumoto, S. Muro, A. Niimi, and M. Mishima Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease Int J Tuberc Lung Dis 16 3 2012 408 414 [Epub 2012 Jan 5]
30. D.E. Griffith et al. Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficienc virus-negative patients J Infect Dis 178 1 1998 121 126
31. P.K. Lam, D.E. Griffith, T.R. Aksamit, S.J. Ruoss, S.M. Garay, C.L. Daley, and A. Catanzaro Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease Am J Respir Crit Care Med 173 2006 1283 1289
32. Y. Kobashi, T. Matsushima, and M. Oka A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease Respir Med 101 2007 130 138
33. D.E. Griffith, B.A. Brown-Elliott, B. Langsjoen, Y. Zhang, X. Pan, W. Girard, K. Nelson, J. Caccitolo, J. Alvarez, S. Shepherd, R. Wilson, E.A. Graviss, and R.J. Wallace Jr. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease Am J Respir Crit Care Med 174 8 2006 Oct 15 928 934 [Epub 2006 Jul 20]
34. S.K. Field Field, and R.L. Cowie Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine Chest 124 2003 1482 1486
35. J.D. Mitchell, J.A. Yu, A. Bishop, M.J. Weyant, and M. Pomerantz Thoracoscopic lobectomyand segmentectomy for infectious lung disease Ann Thorac Surg 93 4 2012 Apr 1033 1039 [discussion 1039-40]
36. J.A. Yu, M. Pomerantz, A. Bishop, M.J. Weyant, and J.D. Mitchell Lady Windermererevisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease Eur J Cardiothorac Surg 40 3 2011 Sep 671 675
37. K.K. Davis, P.N. Kao, S.S. Jacobs, and S.J. Ruoss Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series BMC Pulm Med 7 2007 Feb 23 2
38. J. van Ingen, E.F. Egelund, A. Levin, S.E. Totten, M.J. Boeree, J.W. Mouton, R.E. Aarnoutse, L.B. Heifets, C.A. Peloquin, and C.L. Daley The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment Am J Respir Crit Care Med 186 6 2012 Sep 15 559 565
39. D.E. Griffith, and K.L. Winthrop Mycobacterium avium complex lung disease therapy AmJ Respir Crit Care Med 186 6 2012 Sep 15 477 479
40. A. Sarma, M.E. Heilbrun, K.E. Conner, S.M. Stevens, S.C. Woller, and C.G. Elliott Radiation and chest CT scan examinations: what do we know? Chest 142 3 2012 Sep 750 760
41. K. Jeon, O. Kwon, and N. Lee et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients Am J Respir Crit Care Med 180 2009 896 903
42. T. Harada, Y. Akiyama, A. Kurashima, H. Nagai, K. Tsuyuguchi, T. Fujii, S. Yano, E. Shigeto, T. Kuraoka, A. Kajiki, Y. Kobashi, F. Kokubu, A. Sato, S. Yoshida, T. Iwamoto, and H. Saito Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases J Clin Microbiol 50 11 2012 Nov 3556 3561
43. W.J. Koh, K. Jeon, N.Y. Lee, B.J. Kim, Y.H. Kook, S.H. Lee, Y.K. Park, C.K. Kim, S.J. Shin, G.A. Huitt, C.L. Daley, and O.J. Kwon Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus Am J Respir Crit CareMed 183 3 2011 Feb 1 405 410
44. G.E. Choi, S.J. Shin, C.J. Won, K.N. Min, T. Oh, M.Y. Hahn, K. Lee, S.H. Lee, C.L. Daley, S. Kim, B.H. Jeong, K. Jeon, and W.J. Koh Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance Am J Respir Crit Care Med 186 9 2012 Nov 1 917 925
45. British Thoracic Society Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment Eur Respir J 21 2003 478
46. P.A. Jenkins, I.A. Campbell, and J. Banks et al. Clarithromycin vs. ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy Thorax 63 2008 627 634 [Erratum in: Thorax. 2008 Sep;63:844]
47. C. Andrejak, F.X. Lescure, and E. Pukenyte et al. Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France Thorax 64 2009 291 296
48. J. van Ingen, M.J. Boeree, W.C. de Lange, W. Hoefsloot, S.A. Bendien, C. Magis-Escurra, R. Dekhuijzen, and D. van Soolingen Mycobacterium xenopi clinical relevance and determinants, The Netherlands Emerg Infect Dis 14 3 2008 Mar 385 389
49. R.K. Albert, J. Connett, W.C. Bailey, R. Casaburi, J.A. Cooper Jr., G.J. Criner, J.L. Curtis, M.T. Dransfield, M.K. Han, S.C. Lazarus, B. Make, N. Marchetti, F.J. Martinez, N.E. Madinger, C. McEvoy, D.E. Niewoehner, J. Porsasz, C.S. Price, J. Reilly, P.D. Scanlon, F.C. Sciurba, S.M. Scharf, G.R. Washko, P.G. Woodruff, N.R. Anthonisen COPD Clinical Research Network Azithromycin for prevention of exacerbations of COPD N Engl J Med 365 8 2011 Aug 25 689 698
50. C. Wong, L. Jayaram, N. Karalus, T. Eaton, C. Tong, H. Hockey, D. Milne, W. Fergusson, C. Tuffery, P. Sexton, L. Storey, and T. Ashton Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial Lancet 380 9842 2012 Aug 18 660 667